Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion type Assertion NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_head.
- NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion wasGeneratedBy ECO_0000203 NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_provenance.
- NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion wasDerivedFrom lhgdn-20090331 NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_provenance.
- NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion SIO_000772 15342390 NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_provenance.
- NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion evidence source_evidence_literature NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_provenance.
- NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_assertion description "[Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171402.RANh2ofFpeKigVCPiIacTxNo9BvGAXs-qR2EzbR4bwNIM130_provenance.